By InvitationPhase 2

Tradipitant for Functional Dyspepsia

United States60 participantsStarted 2023-02-09

Plain-language summary

To evaluate the effects of tradipitant relative to placebo on gastric motor functions, satiation, and postprandial symptoms in patients with functional dyspepsia.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able to provide written consent * Body Mass Index (BMI) of 18-35 kg/m2 * Absence of other diseases which could interfere with interpretation of study results Exclusion Criteria: * Current H. pylori infection * Pregnancy or nursing * Recent history of Alcohol Use Disorder or Substance Use Disorder

What they're measuring

Accommodation gastric volumes measured by single photon emission computed tomography (SPECT)

Timeframe: 4 Weeks

Trial details

NCT IDNCT05653310

SponsorXiao Jing (Iris) Wang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Functional Dyspepsia trials